Relative cost of etanercept versus infliximab in the treatment of rheumatoid arthritis.

被引：0
|
作者：
Sweis, BP
Ellman, CJ
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Jordan, Amman, Jordan
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Cost minimization analysis of rituximab versus infliximab, adalimumab and etanercept for rheumatoid arthritis from a payer perspective in Brazil
    Saggia, M. G.
    Santos, E. A.
    Nasciben, V
    VALUE IN HEALTH, 2007, 10 (06) : A247 - A247
  • [22] Enbrel® (etanercept) pharmacokinetics in patients with rheumatoid arthritis.
    Kremer, JM
    Spencer-Green, GT
    Hanna, RK
    Korth-Bradley, JM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S229 - S229
  • [23] Etanercept in children with polyarticular juvenile rheumatoid arthritis.
    Lovell, DJ
    Giannini, EH
    Reiff, A
    Cawkwell, GD
    Silverman, ED
    Nocton, JJ
    Stein, LD
    Gedalia, A
    Ilowite, NT
    Wallace, CA
    Whitmore, J
    Finck, BK
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11): : 763 - 769
  • [24] ETANERCEPT ORIGINATOR VERSUS ITS BIOSIMILAR (SB4) FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. ARE THEY TRULY SIMILAR?
    Rokad, Aasiyah
    Kearsley-Fleet, Lianne
    Watson, Kath
    Lunt, Mark
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2022, 61 : I8 - I8
  • [25] A cost-efficacy analysis of etanercept and infliximab in the treatment of psoriatic arthritis
    Yu, EB
    Woolley, JM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 400 - 400
  • [26] The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Vergel, Y. Bravo
    Hawkins, N. S.
    Claxton, K.
    Asseburg, C.
    Palmer, S.
    Woolacott, N.
    Bruce, I. N.
    Sculpher, M. J.
    RHEUMATOLOGY, 2007, 46 (11) : 1729 - 1735
  • [27] Etanercept versus infliximab plus methotrexate in rheumatoid arthritis: A cost-effectiveness analysis from the Italian NHS perspective
    Lopatriello, S
    Berto, P
    VALUE IN HEALTH, 2003, 6 (06) : 725 - 725
  • [28] Cost of Etanercept, Adalimumab, and Infliximab in Patients with Rheumatoid Arthritis with Employer Provided Health Insurance
    Bonafede, Machaon
    Watson, Crystal
    Joseph, George
    Princic, Nicole
    Harrison, David J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S778 - S778
  • [29] The cost of glucocorticoids in rheumatoid arthritis.
    Pisu, M
    James, NT
    Saag, KG
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S167 - S167
  • [30] Cost-effectiveness of low dose corticosteroids versus nsaids in the treatment of rheumatoid arthritis.
    Bae, SC
    Corzillius, M
    Kuntz, KM
    Liang, MH
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S249 - S249
12345